MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Speech features in Korean Parkinson’s disease patients: A prospective cohort study

    D. Yoo, S. Cho, J. Kim, J. Bang (Seoul, Republic of Korea)

    Objective: In this study, we explored speech characteristics of Korean Parkinson's disease (PD) patients and their usefulness as a biomarker. Background: Previous studies have shown…
  • 2024 International Congress

    Decoding Fatigue in Parkinson’s Disease: Exploring Multifactorial Associations

    F. Sarmento, G. Lamp, V. Srikar Lavu, A. S. Madamangalam, J. K. Wong (Gainesville, USA)

    Objective: To examine the relationship between fatigue, clinical demographics and NMS in PD patients to inform targeted treatment approaches. Background: Non-motor symptoms (NMS) in Parkinson’s…
  • 2024 International Congress

    Prospective and Controlled Glucocerebrosidase-related Parkinson’s Disease Evaluation of Non-Motor Symptoms (PROGENS-PD)

    I. Muro, L. López-Manzanares, P. Lorenzo, E. Casas, B. González, J. Masabanda, A. Arroyo, A. Hurtado, JP. Romero (Madrid, Spain)

    Objective: To outline the protocol for an upcoming study aimed at describing the non-motor symptoms (NMS) in Parkinson’s disease (PD) patients with heterozygous glucocerebrosidase (GBA)…
  • 2024 International Congress

    Clinical and Neuroimaging Biomarker Predictors of Autonomic Dysfunction in Parkinson’s Disease: A Study Using PPMI Data

    A. Oliveira Franco, M. Machado Schlindwein, J. Rossi Catao, D. Teixeira-Dos-Santos, A. Bieger, T. Hugentobler Schlickmann, L. Angi Souza, C. Mattjie, F. Suzuki, G. Magalhães Pereira, L. Silveira Kupssinskü, L. Vinícius Moura, R. Ravazio, S. Duarte Pinto, M. de Bastiani, R. Barros, E. Zimmer, A. Schumacher Schuh (Porto Alegre, Brazil)

    Objective: To evaluate whether clinical and neuroimaging baseline markers predict the onset of significant dysautonomia over five years in individuals with idiopathic, de novo Parkinson's…
  • 2024 International Congress

    Effects on Speech After the Use of Swallow Against Resistance Exercise Device in Parkinson’s Disease Patients

    R. Lee, H. Hassan, E. Jackowiak, R. Brennan, M. Kern, R. Shaker (Milwaukee, USA)

    Objective: To evaluate the effect on speech after a strength training exercise targeting the swallowing biomechanics in Parkinson’s disease (PD) patients. Background: Dysarthria and dysphagia…
  • 2024 International Congress

    Comparasion of Motor, Non-motor, Social Aspects between Women with Parkinson’s Disease with and Without Sexual Dysfunction

    K. Nobrega, B. Alexandre, M. Braga, A. Helene, A. Roque, I. Nascimento, M. Piemonte (Sao Paulo, Brazil)

    Objective: This study aimed to compare the motor, non-motor, and social aspects of women with Parkinson's disease who have sexual dysfunction and those who do…
  • 2024 International Congress

    Evaluating the Impact of the Pain Self-Management Program in PD

    A. Zawar (Lynnwood, USA)

    Objective: The program aims to provide PD individuals with skill sets, knowledge, and tools necessary to effectively self-manage their pain through non-pharmacological approaches. By empowering…
  • 2024 International Congress

    Understanding the earliest phases of Parkinson’s disease (PD) – an expanding opportunity to study ‘at-risk’/early/prodromal PD in the Global Parkinson’s Genetics Program (GP2)

    K. Atterling Brolin, S. Jasaityte, M. Teferra, M. Rezaei, L. Jones, J. Trinh, E. Stafford, M. Makarious, M T. Periñan, L. Lange, S. Waters, A. Martinez Carrasco, M. Tan, H. Iwaki, H. Morris, C. Blauwendraat, A. Singleton, Z. Gan-Or, A. Noyce (Lund, Sweden)

    Objective: To identify and recruit at-risk/early/prodromal Parkinson’s disease (PD) cohorts around the world to the Global Parkinson’s Genetics Program (GP2, http://gp2.org/) and build a global…
  • 2024 International Congress

    Parkinson’s Families Project: A UK-Wide Study of Early Onset and Familial Parkinson’s Disease

    R. Real, Z-H. Fang, C. Towns, T. Schmaderer, S. Jasaityte, M. Tan, M. Pollard, L. Lange, R. Tilney, A. Singleton, C. Blauwendraat, C. Klein, H. Morris (London, United Kingdom)

    Objective: The Parkinson’s Families Project is a UK-wide study aimed at identifying genetic variation associated with familial and early-onset Parkinson's disease (PD). Background: Rare variants…
  • 2024 International Congress

    When Off Can Cost Life: Myocardial Infarction Due to Spontaneous Coronary Dissection as a Catastrophic Manifestation in Advanced Parkinson’s Disease.

    S. Poveda, T. Lopez, B. Pascual Sedano, A. Campolongo (Bogotá, Colombia)

    Objective: Describe a patient with PD who suffered an acute myocardial infarction during a severe OFF period. Background: Advanced PD is characterized by complications including…
  • « Previous Page
  • 1
  • …
  • 257
  • 258
  • 259
  • 260
  • 261
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley